Brief: Amniotics Gets Positive Information About Safety Data For Pulmostem In Clinical Study
02/03/2023 10:32
March 2 (Reuters) - Amniotics AB (publ) AMNI.ST :
* AMNIOTICS AB RECEIVES POSITIVE INFORMATION ABOUT SAFETY
DATA FOR
PULMOSTEM IN CLINICAL STUDY
* STUDY DOSE ESCALATION COMMITTEE HAS ANNOUNCED THAT NO
DOSE-LIMITING SAFETY FINDINGS WERE NOTED IN SECOND DOSE LEVEL OF
TWO MILLION CELLS PER KILOGRAM OF BODY WEIGHT
Source text for Eikon: ID:nMFN6fVN
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan